-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CxwJNp+CtBKtb8eC0LGrD6f4mgpZ/S64vxk7/8XTtSGd7WMQhgKbykcWr/48jc5J GoBYme4MEtKDNwTEDB8vkg== 0000920691-01-500002.txt : 20010213 0000920691-01-500002.hdr.sgml : 20010213 ACCESSION NUMBER: 0000920691-01-500002 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-59397 FILM NUMBER: 1531850 BUSINESS ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584537200 MAIL ADDRESS: STREET 1: 6166 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TRIPOS INC CENTRAL INDEX KEY: 0000920691 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 431454986 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1699 SOUTH HANLEY RD STREET 2: STE 303 CITY: ST LOUIS STATE: MO ZIP: 63144 BUSINESS PHONE: 3146471099 MAIL ADDRESS: STREET 1: 1699 SOUTH HANLEY RD STREET 2: STE 303 CITY: ST LOUIS STATE: MO ZIP: 63144 SC 13G 1 arena13g.htm SCH 13G FOR HOLDINGS IN ARENA PHARMACEUTICALS Schedule 13G-FDCC investment

OMB APPROVAL

OMB Number: 3235-0145

Expires: October 31, 2002

Estimated average burden

hours per response. . . 14.9

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

ARENA PHARMACEUTICALS, INC.

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

04004 71 02

(CUSIP Number)

 

December 31, 2000

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[  ] Rule 13d-1(b)

[  ] Rule 13d-1(c)

[X] Rule 13d-1(d)

Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G

CUSIP No. 040047102

 

Page 2 of 5 Pages

1

NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

TRIPOS, INC.

43-1454986

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) [  ]

(b) [  ] 

3

SEC USE ONLY 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

UTAH

NUMBER OF

5

SOLE VOTING POWER   2,015,840

SHARES

BENEFICIALLY

OWNED BY

6

SHARED VOTING POWER

EACH

REPORTING

PERSON

7

SOLE DISPOSITIVE POWER   2,015,840

WITH

8

SHARED DISPOSITIVE POWER

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,015,840

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.4%

12

TYPE OF REPORTING PERSON*

CO

 

This Amendment No. 1 amends the initial Schedule 13G filed on July 28, 2000 by Tripos, Inc. relating to the Common Stock, par value $0.0001 per share, of Arena Pharmaceuticals, Inc.

Item 1.

(a) Name of Issuer:

Arena Pharmaceuticals, Inc.

(b) Address of Issuer's Principal Executive Offices:

6166 Nancy Ridge Drive

San Diego, CA 92121

Item 2.

(a) Name of Person Filing:

Tripos, Inc.

(b) Address of Principal Business Office or, if none, Residence:

1699 South Hanley Road

St. Louis, MO 63144

(c) Citizenship:

Tripos, Inc. is organized under the laws of the State of Utah and has its principal place of business in St. Louis, Missouri.

(d) Title of Class of Securities:

Common Stock, par value $.0001 per share

(e) CUSIP Number:

04004 71 02

Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with 240.13d- 1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Item 4. Ownership.

Item 4 is hereby amended and restated in its entirety as follows:

Provide the following information regarding the aggregate number and percentage

of the class of securities of the issuer identified in Item 1.

As of December 31, 2000:

(a) Amount beneficially owned: 2,015,840.

(b) Percent of class: 9.4%.

(c) Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote 2,015,840.

(ii) Shared power to vote or to direct the vote None.

(iii) Sole power to dispose or to direct the disposition of 2,015,840.

(iv) Shared power to dispose or to direct the disposition of None.

 

Item 5. Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

Item 8. Identification and Classification of Members of the Group

Not applicable.

Item 9. Notice of Dissolution of Group

Not applicable.

Item 10. Certification

Not applicable.

 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 9, 2001

Tripos, Inc.

By: /s/ Colleen A. Martin

Vice President - Finance

Chief Financial Officer

 -----END PRIVACY-ENHANCED MESSAGE-----